| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
PetMed Express, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.16 |
| 52 Week High | US$10.44 |
| 52 Week Low | US$2.60 |
| Beta | 0.70 |
| 11 Month Change | 16.18% |
| 3 Month Change | -15.42% |
| 1 Year Change | -67.08% |
| 33 Year Change | -86.12% |
| 5 Year Change | -80.94% |
| Change since IPO | -47.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| PQM | DE Specialty Retail | DE Market | |
|---|---|---|---|
| 7D | -3.6% | 6.1% | 4.5% |
| 1Y | -67.1% | 23.1% | 13.4% |
Return vs Industry: PQM underperformed the German Specialty Retail industry which returned 23.1% over the past year.
Return vs Market: PQM underperformed the German Market which returned 13.4% over the past year.
Price Volatility
| PQM volatility | |
|---|---|
| PQM Average Weekly Movement | 8.4% |
| Specialty Retail Industry Average Movement | 5.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PQM's share price has been volatile over the past 3 months.
Volatility Over Time: PQM's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 287 | Sandra Campos | www.1800petmeds.com |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PetMed Express, Inc. Fundamentals Summary
| PQM fundamental statistics | |
|---|---|
| Market cap | €67.67m |
| Earnings (TTM) | -€2.31m |
| Revenue (TTM) | €242.50m |
0.3x
P/S Ratio-29.4x
P/E RatioIs PQM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PQM income statement (TTM) | |
|---|---|
| Revenue | US$270.77m |
| Cost of Revenue | US$196.68m |
| Gross Profit | US$74.09m |
| Other Expenses | US$76.67m |
| Earnings | -US$2.57m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.13 |
| Gross Margin | 27.36% |
| Net Profit Margin | -0.95% |
| Debt/Equity Ratio | 0% |
How did PQM perform over the long term?
See historical performance and comparison